Cargando…

A Theranostic Approach to Imaging and Treating Melanoma with (203)Pb/(212)Pb-Labeled Antibody Targeting Melanin

SIMPLE SUMMARY: Metastatic melanoma is a deadly disease that claims thousands of lives each year despite the introduction of several new drugs into the clinic over the past decade, inspiring the need for novel therapeutics. We investigate targeting melanin pigment, which causes melanoma, with protei...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiao, Rubin, Allen, Kevin J. H., Malo, Mackenzie E., Yilmaz, Orhan, Wilson, John, Nelson, Bryce J. B., Wuest, Frank, Dadachova, Ekaterina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416844/ https://www.ncbi.nlm.nih.gov/pubmed/37568672 http://dx.doi.org/10.3390/cancers15153856

Ejemplares similares

Production, purification, and radiolabeling of the (203)Pb/(212)Pb theranostic pair
por: McNeil, Brooke L., et al.
Publicado: (2021)

Optimized production, purification, and radiolabeling of the (203)Pb/(212)Pb theranostic pair for nuclear medicine
por: McNeil, Brooke L., et al.
Publicado: (2023)

Targeting Melanin in Melanoma with Radionuclide Therapy
por: Allen, Kevin J. H., et al.
Publicado: (2022)

Preclinical Evaluation of a Lead Specific Chelator (PSC) Conjugated to Radiopeptides for (203)Pb and (212)Pb-Based Theranostics
por: Li, Mengshi, et al.
Publicado: (2023)

Comparative Radioimmunotherapy of Experimental Melanoma with Novel Humanized Antibody to Melanin Labeled with 213Bismuth and 177Lutetium
por: Allen, Kevin J. H., et al.
Publicado: (2019)

Mechanistic Insights into Synergy between Melanin-Targeting Radioimmunotherapy and Immunotherapy in Experimental Melanoma
por: Malo, Mackenzie E., et al.
Publicado: (2020)

Development and dosimetry of (203)Pb/(212)Pb-labelled PSMA ligands: bringing “the lead” into PSMA-targeted alpha therapy?
por: dos Santos, José Carlos, et al.
Publicado: (2019)

Effects of Melanized Bacteria and Soluble Melanin on the Intestinal Homeostasis and Microbiome In Vivo
por: Zhang, Yong-guo, et al.
Publicado: (2022)

Search of ligands suitable for (212)Pb/(212)Bi in vivo generators
por: Bartoś, Barbara, et al.
Publicado: (2012)

Influence of the Molar Activity of (203/212)Pb-PSC-PEG(2)-TOC on Somatostatin Receptor Type 2-Binding and Cell Uptake
por: Pretze, Marc, et al.
Publicado: (2023)

(212)Pb: Production Approaches and Targeted Therapy Applications
por: Kokov, Konstantin V., et al.
Publicado: (2022)

Imaging of (212)Pb in mice with a clinical SPECT/CT
por: Kvassheim, Monika, et al.
Publicado: (2023)

[(212)Pb]Pb-eSOMA-01: A Promising Radioligand for Targeted Alpha Therapy of Neuroendocrine Tumors
por: Chapeau, Dylan, et al.
Publicado: (2023)

Biodistribution of a Radiolabeled Antibody in Mice as an Approach to Evaluating Antibody Pharmacokinetics
por: Allen, Kevin J. H., et al.
Publicado: (2018)

An Experimental Generator for Production of High-Purity (212)Pb for Use in Radiopharmaceuticals
por: Li, Ruth Gong, et al.
Publicado: (2023)

Safety Evaluation of an Alpha-Emitter Bismuth-213 Labeled Antibody to (1→3)-β-Glucan in Healthy Dogs as a Prelude for a Trial in Companion Dogs with Invasive Fungal Infections
por: Helal, Muath, et al.
Publicado: (2020)

Structure-function analysis and therapeutic efficacy of antibodies to fungal melanin for melanoma radioimmunotherapy
por: Nosanchuk, J. D., et al.
Publicado: (2018)

Safety and Efficacy of 188-Rhenium-Labeled Antibody to Melanin in Patients with Metastatic Melanoma
por: Klein, M., et al.
Publicado: (2013)

Adsorption of Pb(II) and Cd(II) by Squid Ommastrephes bartrami Melanin
por: Chen, Shiguo, et al.
Publicado: (2009)

(203)Pb-VMT-α-NET Scintigraphy of a Patient With Neuroendocrine Tumor
por: Müller, Dirk, et al.
Publicado: (2023)

Factors Influencing the Therapeutic Efficacy of the PSMA Targeting Radioligand (212)Pb-NG001
por: Stenberg, Vilde Yuli, et al.
Publicado: (2022)

CD46 targeted (212)Pb alpha particle radioimmunotherapy for prostate cancer treatment
por: Li, Jun, et al.
Publicado: (2023)

Theranostic Imaging Surrogates for Targeted Alpha Therapy: Progress in Production, Purification, and Applications
por: Nelson, Bryce J. B., et al.
Publicado: (2023)

Toxicological Studies of (212)Pb Intravenously or Intraperitoneally Injected into Mice for a Phase 1 Trial
por: Milenic, Diane E., et al.
Publicado: (2015)

Safety and Outcome Measures of First-in-Human Intraperitoneal α Radioimmunotherapy With (212)Pb-TCMC-Trastuzumab
por: Meredith, Ruby F., et al.
Publicado: (2018)

(212)Pb α-Radioimmunotherapy Targeting CD38 in Multiple Myeloma: A Preclinical Study
por: Quelven, Isabelle, et al.
Publicado: (2020)

Optimized SPECT Imaging of (224)Ra α-Particle Therapy by (212)Pb Photon Emissions
por: Mikalsen, Lars Tore Gyland, et al.
Publicado: (2023)

(212)Pb-Labeled Antibody 225.28 Targeted to Chondroitin Sulfate Proteoglycan 4 for Triple-Negative Breast Cancer Therapy in Mouse Models
por: Kasten, Benjamin B., et al.
Publicado: (2018)

(212)Pb-radioimmunotherapy potentiates paclitaxel-induced cell killing efficacy by perturbing the mitotic spindle checkpoint
por: Yong, K J, et al.
Publicado: (2013)

Jet Fragmentation Functions Measured in PbPb Collisions with CMS
por: Yilmaz, Yetkin
Publicado: (2011)

High yield cyclotron production of a novel (133/135)La theranostic pair for nuclear medicine
por: Nelson, Bryce J. B., et al.
Publicado: (2020)

In Vitro and In Vivo Characterization of (89)Zirconium-Labeled Lintuzumab Molecule
por: Allen, Kevin J. H., et al.
Publicado: (2022)

Daratumumab-(225)Actinium conjugate demonstrates greatly enhanced antitumor activity against experimental multiple myeloma tumors
por: Dawicki, Wojciech, et al.
Publicado: (2019)

A Novel Single-Step-Labeled (212)Pb-CaCO(3) Microparticle for Internal Alpha Therapy: Preparation, Stability, and Preclinical Data from Mice
por: Li, Ruth Gong, et al.
Publicado: (2021)

Evaluating the Combination of Radioimmunotherapy and Immunotherapy in a Melanoma Mouse Model
por: Jiao, R., et al.
Publicado: (2020)

Melanin-Based Contrast Agents for Biomedical Optoacoustic Imaging and Theranostic Applications
por: Longo, Dario Livio, et al.
Publicado: (2017)

Bottomonia in pp, pPb and PbPb
por: Filipovic, Nicolas
Publicado: (2015)

Gene expression profiling upon (212)Pb-TCMC-trastuzumab treatment in the LS-174T i.p. xenograft model
por: Yong, Kwon J, et al.
Publicado: (2013)

Evaluation of the PSMA-Binding Ligand (212)Pb-NG001 in Multicellular Tumour Spheroid and Mouse Models of Prostate Cancer
por: Stenberg, Vilde Yuli, et al.
Publicado: (2021)

Dual targeting with (224)Ra/(212)Pb-conjugates for targeted alpha therapy of disseminated cancers: A conceptual approach
por: Juzeniene, Asta, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ntdnvqcqjvm76dunjmgesbbims